HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cancer morbidity in Swedish asphalt workers.

AbstractBACKGROUND:
Some studies have indicated an increased risk of lung cancer among asphalt workers. This study investigates the risk of lung cancer in Swedish asphalt workers.
METHODS:
A cohort of 6,150 asphalt workers, mainly employed in road construction, was compared to the general population, and to a reference group of construction workers not exposed to asphalt fumes. The exposure to polyaromatic hydrocarbons (PAH) at paving in Sweden during the 1980s and 1990s were estimated to be in the order of one or a few micrograms per cubic meter, but must have been higher in earlier years.
RESULTS:
Thirty-two lung cancer cases were observed among asphalt workers. The relative risk (SIR) and 95% confidence intervals were 0.98 (0.67-1.39). The corresponding relative risk, as compared to a group of construction workers and adjusted for smoking habits, was 1.03 (0.70-1.45). We found no increased risk for other cancers investigated or death in other lung diseases.
CONCLUSIONS:
Asphalt workers do not have any increased lung cancer risk from exposure to fumes and gases from asphalt at the exposure levels that occurred in Sweden during the 1960s and 1970s.
AuthorsIngvar A Bergdahl, Bengt Järvholm
JournalAmerican journal of industrial medicine (Am J Ind Med) Vol. 43 Issue 1 Pg. 104-8 (Jan 2003) ISSN: 0271-3586 [Print] United States
PMID12494427 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2003 Wiley-Liss, Inc.
Chemical References
  • Hydrocarbons
  • asphalt
Topics
  • Cause of Death
  • Humans
  • Hydrocarbons
  • Incidence
  • Inhalation Exposure
  • Lung Neoplasms (epidemiology, mortality)
  • Neoplasms (epidemiology, mortality)
  • Occupational Exposure
  • Risk Assessment
  • Sweden (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: